These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2168225)

  • 41. Isolation and characterization of thrombomodulin from human placenta.
    Salem HH; Maruyama I; Ishii H; Majerus PW
    J Biol Chem; 1984 Oct; 259(19):12246-51. PubMed ID: 6090461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation/inactivation of human factor V by plasmin.
    Lee CD; Mann KG
    Blood; 1989 Jan; 73(1):185-90. PubMed ID: 2521293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and D-Phe-Pro-Arg-Ch2Cl.
    Yang XJ; Blajchman MA; Craven S; Smith LM; Anvari N; Ofosu FA
    Biochem J; 1990 Dec; 272(2):399-406. PubMed ID: 2268268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conversion of recombinant hirudin to the natural form by in vitro tyrosine sulfation. Differential substrate specificities of leech and bovine tyrosylprotein sulfotransferases.
    Niehrs C; Huttner WB; Carvallo D; Degryse E
    J Biol Chem; 1990 Jun; 265(16):9314-8. PubMed ID: 2345174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and analysis of the core protein of the protease-resistant intracellular chondroitin sulfate E proteoglycan from the interleukin 3-dependent mouse mast cell.
    Stevens RL; Otsu K; Austen KF
    J Biol Chem; 1985 Nov; 260(26):14194-200. PubMed ID: 3932350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tyrosine O-sulfation.
    Corbeil D; Thiele C; Huttner WB
    Curr Protoc Protein Sci; 2005 Mar; Chapter 14():14.7.1-14.7.14. PubMed ID: 18429275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polyomavirus major capsid protein VP1 is modified by tyrosine sulfuration.
    Ludlow JW; Consigli RA
    J Virol; 1987 May; 61(5):1708-11. PubMed ID: 3033299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of human factors X and Xa to HepG2 and J82 human tumor cell lines. Evidence that factor Xa binds to tumor cells independent of factor Va.
    Sakai T; Kisiel W
    J Biol Chem; 1990 Jun; 265(16):9105-13. PubMed ID: 2160956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An extensive interaction interface between thrombin and factor V is required for factor V activation.
    Myles T; Yun TH; Hall SW; Leung LL
    J Biol Chem; 2001 Jul; 276(27):25143-9. PubMed ID: 11312264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new model for coagulation factor V suggesting a unique mechanism of activation.
    Dahlbäck B
    Scand J Clin Lab Invest Suppl; 1988; 191():47-61. PubMed ID: 3247583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification, purification, and characterization of cell-surface retention sequence-binding proteins from human SK-Hep cells and bovine liver plasma membranes.
    Boensch C; Kuo MD; Connolly DT; Huang SS; Huang JS
    J Biol Chem; 1995 Jan; 270(4):1807-16. PubMed ID: 7829517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombin-catalyzed activation of human coagulation factor V.
    Suzuki K; Dahlbäck B; Stenflo J
    J Biol Chem; 1982 Jun; 257(11):6556-64. PubMed ID: 7076681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
    Marquette KA; Pittman DD; Kaufman RJ
    Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The activation of factor V by factor Xa or alpha-chymotrypsin and comparison with thrombin and RVV-V action. An improved factor V isolation procedure.
    Smith CM; Hanahan DJ
    Biochemistry; 1976 May; 15(9):1830-8. PubMed ID: 1268197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biosynthesis of heparin. O-sulfation of D-glucuronic acid units.
    Kusche M; Lindahl U
    J Biol Chem; 1990 Sep; 265(26):15403-9. PubMed ID: 2118524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The regulation of human factor V by a neutrophil protease.
    Oates AM; Salem HH
    Blood; 1987 Sep; 70(3):846-51. PubMed ID: 3304463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Occurrence of tyrosine sulfate in proteins--a balance sheet. 1. Secretory and lysosomal proteins.
    Hille A; Braulke T; von Figura K; Huttner WB
    Eur J Biochem; 1990 Mar; 188(3):577-86. PubMed ID: 2331986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A rat osteogenic cell line (UMR 106-01) synthesizes a highly sulfated form of bone sialoprotein.
    Midura RJ; McQuillan DJ; Benham KJ; Fisher LW; Hascall VC
    J Biol Chem; 1990 Mar; 265(9):5285-91. PubMed ID: 2318894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factor V.
    Kalafatis M; Krishnaswamy S; Rand MD; Mann KG
    Methods Enzymol; 1993; 222():224-36. PubMed ID: 8412796
    [No Abstract]   [Full Text] [Related]  

  • 60. Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog.
    Lollar P; Parker ET
    J Biol Chem; 1991 Jul; 266(19):12481-6. PubMed ID: 1905722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.